Achalasia: Difference between revisions

(Marked this version for translation)
 
(7 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Background==
<languages/>
<translate>
 
 
==Background== <!--T:1-->
 
<!--T:2-->
[[File:Gray1032.png|thumb|Posterior view of the position and relation of the esophagus in the cervical region and in the posterior mediastinum.]]
[[File:Layers of the GI Tract english.svg|thumb|Layers of the GI track: the mucosa, submucosa, muscularis, and serosa.]]
[[File:Illu esophagus.jpg|thumb|Esophagus anatomy and nomenclature based on two systems.]]
*Inability of LES to relax and loss of normal peristalsis <ref>Krill JT, Naik RD, Vaezi MF. Clinical management of achalasia: current state
*Inability of LES to relax and loss of normal peristalsis <ref>Krill JT, Naik RD, Vaezi MF. Clinical management of achalasia: current state
of the art. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831602/ Clin Exp Gastroenterol. 2016 Apr 4;9:71-82.]</ref>
of the art. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831602/ Clin Exp Gastroenterol. 2016 Apr 4;9:71-82.]</ref>


==Clinical Features==
 
*Dysphagia
 
==Clinical Features== <!--T:3-->
 
<!--T:4-->
*[[Special:MyLanguage/Dysphagia|Dysphagia]]
*Regurgitation
*Regurgitation
*[[Chest pain]]
*[[Special:MyLanguage/Chest pain|Chest pain]]
**Esophageal spasm can be eight, crushing retrosternal much like ACS
**Esophageal spasm can feel like tight, crushing retrosternal pain similar to ACS


==Differential Diagnosis==
 
 
==Differential Diagnosis== <!--T:5-->
 
<!--T:6-->
*[[Special:MyLanguage/Ingested foreign body|Ingested foreign body]]
*Esophageal carcinoma - ''dysphagia predominantly for solid foods during initial stages''
*Esophageal carcinoma - ''dysphagia predominantly for solid foods during initial stages''
*Reflux esophagitis - ''dysphagia results from inflammatory swelling or a fibrotic stricture''
*Reflux [[Special:MyLanguage/esophagitis|esophagitis]] - ''dysphagia results from inflammatory swelling or a fibrotic stricture''
*Pseudoachalasia - ''underlying malignancy mimics achalasia''
*Pseudoachalasia - ''underlying malignancy mimics achalasia''
*Connective tissue disorders - ''e.g. systemic sclerosis''
*[[Special:MyLanguage/Connective tissue disorders|Connective tissue disorders]] - ''e.g. [[Special:MyLanguage/scleroderma|systemic sclerosis]]''
*Esophageal spasm - ''chest pain a predominant feature''
*Esophageal spasm - ''chest pain a predominant feature''


==Evaluation==
 
 
==Evaluation== <!--T:7-->
 
<!--T:8-->
*Upper GI
*Upper GI
**Esophageal dilatation
**Esophageal dilatation
**Birds beak sign  
**Birds beak sign  
[[File:Birds Beak.JPG|thumbnail|Barrium swallow showing birds beak appearance]]
[[File:Birds Beak.JPG|thumbnail|Barrium swallow showing birds beak appearance]]
*Esophageal Manometry
*Esophageal Manometry
[[File:Manometry.jpg|thumbnail|Aperistaltic contractions, increased intraesophageal pressure, and failure of relaxation of the lower esophageal sphincter.]]
[[File:Manometry.jpg|thumbnail|Aperistaltic contractions, increased intraesophageal pressure, and failure of relaxation of the lower esophageal sphincter.]]


==Management==
 
*Trial of antispasmodic for [[Esophageal Spasm]]  
 
**Nifedipine
==Management== <!--T:9-->
 
<!--T:10-->
*Trial of antispasmodic for esophageal spasm
**[[Special:MyLanguage/Nifedipine|Nifedipine]]
*Surgical intervention
*Surgical intervention
**Baloon dilatation
**Balloon dilatation
**Botulinum toxin injection <ref>Nassri A, Ramzan Z. Pharmacotherapy for the management of achalasia: Current status, challenges and future directions. World J Gastrointest Pharmacol Ther. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635155/ 2015 Nov 6;6(4):145-55.]</ref>
**Botulinum toxin injection <ref>Nassri A, Ramzan Z. Pharmacotherapy for the management of achalasia: Current status, challenges and future directions. World J Gastrointest Pharmacol Ther. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635155/ 2015 Nov 6;6(4):145-55.]</ref>
**Myomectomy
**Myomectomy
Line 36: Line 61:
*Treatment may improve dysphagia, but there is no cure and swallowing never completely normalizes
*Treatment may improve dysphagia, but there is no cure and swallowing never completely normalizes


==Disposition==


==See Also==
*[[Ingested foreign body]]


==External Links==
==Disposition== <!--T:11-->
 
 
==See Also== <!--T:12-->
 
<!--T:13-->
*[[Special:MyLanguage/Ingested foreign body|Ingested foreign body]]
 
 
 
==External Links== <!--T:14-->
 


==References==
==References== <!--T:15-->
 
<!--T:16-->
<references/>
<references/>


<!--T:17-->
[[Category:GI]]
[[Category:GI]]
</translate>

Latest revision as of 16:54, 6 January 2026

Other languages:


Background

Posterior view of the position and relation of the esophagus in the cervical region and in the posterior mediastinum.
Layers of the GI track: the mucosa, submucosa, muscularis, and serosa.
Esophagus anatomy and nomenclature based on two systems.
  • Inability of LES to relax and loss of normal peristalsis [1]


Clinical Features

  • Dysphagia
  • Regurgitation
  • Chest pain
    • Esophageal spasm can feel like tight, crushing retrosternal pain similar to ACS


Differential Diagnosis


Evaluation

  • Upper GI
    • Esophageal dilatation
    • Birds beak sign
Barrium swallow showing birds beak appearance
  • Esophageal Manometry
Aperistaltic contractions, increased intraesophageal pressure, and failure of relaxation of the lower esophageal sphincter.


Management

  • Trial of antispasmodic for esophageal spasm
  • Surgical intervention
    • Balloon dilatation
    • Botulinum toxin injection [2]
    • Myomectomy
    • Consider gastrostomy for frail and older patients
  • Patients need to eat upright at all times.
  • Treatment may improve dysphagia, but there is no cure and swallowing never completely normalizes


Disposition

See Also


External Links

References

  1. Krill JT, Naik RD, Vaezi MF. Clinical management of achalasia: current state of the art. Clin Exp Gastroenterol. 2016 Apr 4;9:71-82.
  2. Nassri A, Ramzan Z. Pharmacotherapy for the management of achalasia: Current status, challenges and future directions. World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):145-55.